NCT03819023 is a NA clinical trial of Respilife monitor in Respiration Disorders, sponsored by Bioresp Technologies, Inc..

Who is sponsoring NCT03819023?

NCT03819023 is sponsored by Bioresp Technologies, Inc..

What drugs are being tested in NCT03819023?

Interventions in NCT03819023: Respilife monitor.

What condition does NCT03819023 study?

NCT03819023 studies Respiration Disorders.

Is NCT03819023 still recruiting?

NCT03819023 is currently completed. Last updated 4 April 2019.

Last reviewed 2019-04-04 · How we verify

NCT03819023

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Validation of RespiLife for Detection of Respiratory Suppression

Completed NA Last updated 4 April 2019

What this trial tests

NA trial testing Respilife monitor in Respiration Disorders in 30 participants. Completed in 20 March 2019.

Timeline

20 December 2018

Primary endpoint
2 March 2019

20 March 2019

Quick facts

Lead sponsor	Bioresp Technologies, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	30
Start date	20 December 2018
Primary completion	2 March 2019
Estimated completion	20 March 2019
Sites	1 location across United States

Drugs / interventions tested

Respilife monitor

Conditions studied

Respiration Disorders — all drugs for Respiration Disorders →

Sponsor

Bioresp Technologies, Inc.

Who can join

Adults 18 to 80, any sex, with Respiration Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the accuracy of RespiLife diagnostic technology for detection of respiratory rate and oxygen saturation in human subjects. This includes evaluation of Bioresp's RespiLife and its accuracy for measurement of respiratory rate and oxygen saturation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Respiration Disorders

Currently open trials in the same condition.

NCT06271213 — The Gut-Lung Axis and Respiratory Illness in Children · recruiting
NCT06019949 — Spinal Cord Stimulation for Respiratory Rehabilitation in Patients With Chronic Spinal Cord Injury · NA · recruiting
NCT03709199 — Long Term Follow up of Children Enrolled in the REDvent Study · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03819023 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bioresp Technologies, Inc.
Last refreshed: 4 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03819023.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing